Literature DB >> 19165447

[Dyspnoea--a multifactorial and multidimensional symptom].

Katharina Doppler1, Josef Deutsch.   

Abstract

The treatment of dyspnoea is a considerable challenge in palliative care. Respiratory problems, besides pain, belong to the most common symptoms of terminally ill patients. Invasiveness of diagnostic measures and treatment options demand a critical evaluation of the patient's burden and the expected relief by the therapy. On the basis of a case study of a lung cancer patient, the complexity of different causes of dyspnoea will be discussed. Special consideration will be taken to the psychosocial dimension of dyspnoea.

Entities:  

Mesh:

Year:  2008        PMID: 19165447     DOI: 10.1007/s10354-008-0628-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  8 in total

Review 1.  Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

2.  Lung cancer and dyspnea: the patient's perception.

Authors:  M L Brown; V Carrieri; M J Dodd
Journal:  Oncol Nurs Forum       Date:  1986 Sep-Oct       Impact factor: 2.172

3.  [Dyspnea in the last period of one's life].

Authors:  Josef Deutsch; Franz Zdrahal
Journal:  Wien Med Wochenschr       Date:  2006-05

4.  The perception of breathlessness in asthma.

Authors:  J G Burdon; E F Juniper; K J Killian; F E Hargreave; E J Campbell
Journal:  Am Rev Respir Dis       Date:  1982-11

5.  The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients.

Authors:  E Bruera; N Kuehn; M J Miller; P Selmser; K Macmillan
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

6.  [Consideration, assessment and treatment of difficulty in breathing in palliative medicine].

Authors:  S Roller
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2000-09

7.  Dyspnea in terminally ill cancer patients.

Authors:  D B Reuben; V Mor
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

8.  Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.

Authors:  P Hopwood; R J Stephens
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.